Repligen | RGEN - 销售毛利

金融业

USD

USD 2.93B

现金及等价物

USD 582.65M

USD 85.97M

USD 1.16B

USD 126.21M

USD 546.59M

USD 19.98M

USD 40.01M

1.78K

EPS每股收益

USD 0.48

股本和储备

USD 2.11B

USD 108.28M

债务利息支出

USD 5.58M

USD 7.31M

USD 546.59M

USD 6.42B

USD 8.33M

USD 174.27M

USD 19.98M

普通股股本

USD 56.4M

109.48

USD 19.11M

USD 194M

销售和管理费用

USD 76.54M

USD 179.26M

贸易债权人

USD 34.66M

应收帐款人

USD 151.55M

	销售毛利	更改		日
Agilent	USD 946M		44M	2025-12
Align Technology	USD 736.59M		53M	2026-03
Bio Techne	USD 208.29M		17.01M	2026-03
BioMarin Pharmaceutical	USD 571.21M		141.8M	2026-03
Bristol-Myers Squibb	USD 8.41B		381M	2025-12
Bruker	USD 379.8M		69.4M	2026-03
Charles River Laboratories	USD 279.32M		7.36M	2026-03
Danaher	USD 3.59B		375M	2026-03
Dentsply International	USD 427M		16M	2026-03
General Electric Aerospace	USD 4.24B		439M	2026-03
Henry Schein	USD 1.07B		7M	2026-03
Illumina	USD 721M		38M	2026-03
IQVIA Holdings	USD 1.07B		52M	2026-03
Mettler Toledo International	USD 675.44M		65.98M	2025-12
Myriad Genetics	USD 146.8M		3M	2025-12
OraSure Technologies	USD 11.34M		435K	2025-12
Pacific Biosciences Of California	USD 15.74M		601K	2025-12
Pfizer	USD 11.04B		1.24B	2026-03
Repligen	USD 108.28M		4.45M	2026-03
Revvity	USD 387.66M		34M	2026-03
Standard Biotools	USD 11.38M		1.9M	2025-12
Thermo Fisher Scientific	USD 4.49B		146M	2026-03
Waters	USD 542M		15.42M	2026-03
West Pharmaceutical Services	USD 296.4M		7.5M	2026-03